Fig. 2From: Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutationExpression level of miR-21, miR-27a, and miR-218 in the plasma of the 34 patients of the validation groupBack to article page